Maison Du Monde Living Center | |
4000 Rodeo Road, Abbeville, Louisiana 70510 | |
(337) 892-2332 | |
Name | Maison Du Monde Living Center |
---|---|
Location | 4000 Rodeo Road, Abbeville, Louisiana |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 128 |
Occupancy Rate | 83.98% |
Medicare ID (CCN) | 195567 |
Legal Business Name | Diversified Healthcare Abbeville, Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1356490049 |
Organization Name | DIVERSIFIED HEALTHCARE ABBEVILLE, LLC |
Doing Business As | MAISON DU MONDE LIVING CENTER |
Address | 4000 Rodeo Rd., Abbeville, LA 70510 |
Phone Number | 337-892-2332 |
News Archive
South Australian researchers are embarking on a $20 million medical and manufacturing research project which could reduce the chance of infection after orthopaedic surgery, thanks to a little help from the humble dragonfly.
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.
Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.
The University of New Mexico Cancer Center has been awarded the highest designation and rating in the United States for cancer treatment and research programs. It has received the National Cancer Institute's "NCI Comprehensive Cancer Center" designation, identifying it as one of the leading cancer centers in the nation and the only such cancer center in New Mexico.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
South Australian researchers are embarking on a $20 million medical and manufacturing research project which could reduce the chance of infection after orthopaedic surgery, thanks to a little help from the humble dragonfly.
The scientific benefits of whole genome sequencing at the Translational Genomics Research Institute will be presented at the 14th International Myeloma Workshop, April 3-7 at the Kyoto International Conference Center.
Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.
The University of New Mexico Cancer Center has been awarded the highest designation and rating in the United States for cancer treatment and research programs. It has received the National Cancer Institute's "NCI Comprehensive Cancer Center" designation, identifying it as one of the leading cancer centers in the nation and the only such cancer center in New Mexico.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 2 |
Total Amount of Fines in Dollars | $3900 |
Number of Payment Denials | 0 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 18.08 | 14.46 |
Percentage of long-stay residents who lose too much weight | 6.63 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 21.18 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.38 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.04 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.51 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.3 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 19.75 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.77 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 6.18 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25.58 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 14.88 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.89 | 95.98 |